EFFECTS OF DOSE, PH AND OSMOLARITY ON INTRANASAL ABSORPTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS

被引:0
作者
SHIMODA, N [1 ]
MAITANI, Y [1 ]
MACHIDA, Y [1 ]
NAGAI, T [1 ]
机构
[1] CHUGAI PHARMACEUT CO LTD, DEPT BUSINESS COORDINAT, DIV DEV & TECHNOL, KITA KU, TOKYO 115, JAPAN
关键词
ERYTHROPOIETIN; INTRANASAL ADMINISTRATION; GLYCOPROTEIN CIRCULATING RETICULOCYTE; BIOAVAILABILITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of dose, pH and osmolarity on the intranasal absorption of a recombinant human erythropoietin (rEPO) solution were studied in male Wistar rats, The intranasal administration of rEPO was evaluated by measuring percentage circulating reticulocytes of red blood cells on a stained blood smear (smear method), and also by measuring residual circulating reticulocyte counts using a microcell counter (sysmex method), Both results suggest that rEPO solution was absorbed through the nasal mucosa of rats without enhancers after a single intranasal administration, The pharmacological availabilities of rEPO after intranasal administration compared with intravenous administration were about 7% and 4%, when estimated by smear method and sysmex method, respectively, The pharmacological activity was enhanced in low pH and hypotonic mannitol solution.
引用
收藏
页码:734 / 739
页数:6
相关论文
共 25 条
[1]  
BALDAMUS CA, 1989, CONTRIBUTIONS NEPHRO, V76
[2]  
BOMMER J, 1988, LANCET, V2, P406
[3]   A TIME-SAVING DEVICE FOR THE COUNTING OF RETICULOCYTES [J].
BRECHER, G ;
SCHNEIDERMAN, M .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1950, 20 (11) :1079-1083
[4]   CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL [J].
ESCHBACH, JW ;
EGRIE, JC ;
DOWNING, MR ;
BROWNE, JK ;
ADAMSON, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) :73-78
[5]   THE EFFECT OF MOLECULAR-SIZE ON THE NASAL ABSORPTION OF WATER-SOLUBLE COMPOUNDS IN THE ALBINO-RAT [J].
FISHER, AN ;
BROWN, K ;
DAVIS, SS ;
PARR, GD ;
SMITH, DA .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (05) :357-362
[6]  
GARNICK MB, 1990, ERYTHROPOIETIN CLIN, P51
[7]  
GOLDWASSER E, 1974, J BIOL CHEM, V249, P4202
[8]   PROGRESS IN PURIFICATION OF ERYTHROPOIETIN [J].
GOLDWASSER, E ;
KUNG, CKH .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 149 (A1) :49-+
[9]  
HAYASHI M, 1985, CHEM PHARM BULL, V33, P2149
[10]  
HIRAI S, 1981, INT J PHARM, V7, P317